Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

158 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prostate-specific membrane antigen.
Fair WR, Israeli RS, Heston WD. Fair WR, et al. Among authors: heston wd. Prostate. 1997 Jul 1;32(2):140-8. doi: 10.1002/(sici)1097-0045(19970701)32:2<140::aid-pros9>;2-q. Prostate. 1997. PMID: 9215402 Review.
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems.
Gregor PD, Wolchok JD, Ferrone CR, Buchinshky H, Guevara-Patiño JA, Perales MA, Mortazavi F, Bacich D, Heston W, Latouche JB, Sadelain M, Allison JP, Scher HI, Houghton AN. Gregor PD, et al. Vaccine. 2004 Apr 16;22(13-14):1700-8. doi: 10.1016/j.vaccine.2003.10.048. Vaccine. 2004. PMID: 15068853
Cancer of the prostate: a nutritional disease?
Fair WR, Fleshner NE, Heston W. Fair WR, et al. Urology. 1997 Dec;50(6):840-8. doi: 10.1016/S0090-4295(97)00339-7. Urology. 1997. PMID: 9426711 Review.
Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model.
Cozzi PJ, Malhotra S, McAuliffe P, Kooby DA, Federoff HJ, Huryk B, Johnson P, Scardino PT, Heston WD, Fong Y. Cozzi PJ, et al. Among authors: heston wd. FASEB J. 2001 May;15(7):1306-8. doi: 10.1096/fj.00-0533fje. FASEB J. 2001. PMID: 11344122 No abstract available.
158 results